Insider Transactions

What Collegium Pharmaceutical, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	14
Total trades	0	47

Shares traded

	3 months	12 months
Acquired	0	437,397
Disposed	0	293,093
Net activity	+0	+144,304

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Santini Gino	Director	Jun 08	Exercise / conversion · M	+8,700	$16.49	+$143K	112,483
Freund John Gordon	Director	May 18	Open-market sale · S	−20	$34.05	−$681	83,952
Freund John Gordon	Director	May 15	Open-market sale · S	−4,127	$34.54	−$143K	83,972
Freund John Gordon	Director	May 15	Exercise / conversion · M	+8,700	$16.49	+$143K	88,099
Santini Gino	Director	May 14	Grant / award · A	+8,741	—	—	103,783
Bohlin Garen G	Director	May 14	Grant / award · A	+8,741	—	—	71,000
Lurker Nancy	Director	May 14	Grant / award · A	+8,741	—	—	26,758
Freund John Gordon	Director	May 14	Grant / award · A	+8,741	—	—	79,399
Paya Carlos V	Director	May 14	Grant / award · A	+8,741	—	—	28,323
Balice-Gordon Rita J.	Director	May 14	Grant / award · A	+8,741	—	—	61,370
Glancy Donovan Michael	Director	May 14	Grant / award · A	+17,482	—	—	17,482
Lurker Nancy	Director	May 13	Open-market sale · S	−4,500	$35.97	−$162K	18,017
Bohlin Garen G	Director	May 11	Open-market sale · S	−8,700	$37.18	−$323K	62,259
Bohlin Garen G	Director	May 11	Exercise / conversion · M	+8,700	$16.49	+$143K	70,959
Dieter David	EVP & General Counsel	Mar 18	Open-market sale · S	−13,976	$34.92	−$488K	77,071
Dieter David	EVP & General Counsel	Mar 17	Withheld — tax / exercise cost · F	−8,840	$35.72	−$316K	68,231
Dieter David	EVP & General Counsel	Mar 09	Open-market sale · S	−6,224	$36.65	−$228K	91,047
Dreyer Scott	EVP & Chief Commercial Officer	Mar 03	Disclosed 10b5-1 sale · S	−3,559	$40.99	−$146K	71,770
Dreyer Scott	EVP & Chief Commercial Officer	Mar 03	Disclosed 10b5-1 sale · S	−46,417	$40.36	−$1.87M	75,329
Dieter David	EVP & General Counsel	Feb 10	Withheld — tax / exercise cost · F	−2,781	$46.75	−$130K	97,271

Page 1 of 31 · showing the 20 most recent Sign up free to view all 620 transactions and filter by insider →

Comments